Alyeska Investment Group, L.P. Evolus, Inc. Transaction History
Alyeska Investment Group, L.P.
- $23.4 Billion
- Q1 2025
A detailed history of Alyeska Investment Group, L.P. transactions in Evolus, Inc. stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 225,000 shares of EOLS stock, worth $2.24 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
225,000
Previous 325,000
30.77%
Holding current value
$2.24 Million
Previous $3.59 Million
24.56%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding EOLS
# of Institutions
187Shares Held
52MCall Options Held
142KPut Options Held
58.4K-
Tang Capital Management LLC San Diego, CA5MShares$49.8 Million3.9% of portfolio
-
Perceptive Advisors LLC New York, NY4.13MShares$41.1 Million2.08% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$39.9 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.65MShares$36.4 Million1.98% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.23MShares$32.2 Million0.0% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $559M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...